KCR Video Diary

#HumanBehindEveryNumber – KCR’s patient-centric project about patients in clinical trials

Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber.

Who is #HumanBehindEveryNumber? (trailer)

Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber.

PCT 2016 KCR CEO on patients and big data

KCR’s CEO, Mike Jagielski, talks about the state of clinical trials from patient-centricity to big data.

Latest resources

Hope in the fight against lung cancer

Lung cancer is the second most common malignancy in the world, and is the leading cause of cancer deaths worldwide. In 2012 there were diagnosed more than 1,8 million new lung cancer cases and lung cancer caused more than 1.6 million deaths.

Who Needs Fast Data?

Ensuring you have instant access to your clinical trial data is stressful – you need to invest in smart e-solutions, train your teams in system(s) use, and ensure they work with the data on an ongoing basis, report on it and act when any findings are made as first results flow in. Seems like a lot of work, time and costs when compared to collecting data on various external sources, cleaning it in batches at the end of the study and resolving issues just shortly before closing the database. Why stress your clinical trial team with the additional demands? This article is to elaborate on how “no news” during the life of a trial is bad news and what data management (among other things) can do to help when ensuring access to fast data.

#HumanBehindEveryNumber – KCR’s patient-centric project about patients in clinical trials

Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber.

Who is #HumanBehindEveryNumber? (trailer)

Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber.

Developing Global Solutions for Product Safety - Recent Changes in EU Requirements and New Directions in PV Globalisation

Over the past 20 years, the level of globalisation in the pharmaceutical industry increased significantly for both innovative and generic drugs. International cooperation between regulatory bodies and the harmonisation of regulatory requirements are key elements supporting the effective development of medicines, wide access to advanced therapies and ensuring sufficient safety oversight.

Patient Communities for Rare Diseases

Rare diseases might be life threatening. How rare diseases communities might help patients and their caregivers to be better informed and engaged in their health outcomes?

Placebo Controlled Designs. Ethical Approaches

Despite the continuous development of new treatments, availability of efficient and safe methods remains a great unmet need. This term, ‘methods’, refers to the vast range of approaches to chemical and biologic medications, cell-based therapies, medical devices, psychotherapy and so on. Testing new procedures against placebo is thought to provide the most reliable data on the value of a new solution.

Challenges in Medical Coding - Concomitant Medication Therapy Data in Clinical Trials

Clinical trials are intended to prove or disprove a hypothesis set in the study protocol. For this reason, the quality of captured data plays an important role in the study outcome. From a Data Management (DM) perspective, the aim of the clinical study is to achieve clean, complete and consistent clinical data.